Cargando…
Thrombotic microangiopathy following chimeric antigen receptor T-cell therapy
Introduction: Thrombotic microangiopathy (TMA) is characterized by microangiopathic hemolytic anemia and is associated with a variety of conditions and following hematopoietic stem cell transplantation. Chimeric antigen receptor T-cell (CAR-T) therapy is a novel immunotherapeutic approach using gene...
Autores principales: | Wu, Matthew S., Koirala, Abbal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948748/ https://www.ncbi.nlm.nih.gov/pubmed/36844260 http://dx.doi.org/10.5414/CNCS111045 |
Ejemplares similares
-
Thrombotic microangiopathy associated with lenvatinib therapy
por: Contreras Angulo, Macarena, et al.
Publicado: (2023) -
Acyclovir-induced thrombotic microangiopathy
por: Goli, R., et al.
Publicado: (2017) -
Thrombotic microangiopathy triggered by podocytopathy
por: Veríssimo, Rita, et al.
Publicado: (2021) -
Thrombotic microangiopathy following hump-nosed viper
‘Hypnale’ envenomation
por: Puthra, Shiran, et al.
Publicado: (2020) -
Eculizumab in chemotherapy-induced thrombotic microangiopathy
por: Schulte-Kemna, Lena, et al.
Publicado: (2020)